Our findings demonstrate a learning curve associated with the combined approach of CRS and PIC.
Raleigh, NC (PRWEB) September 09, 2015
Scientists in Australia have released the results of a study tracking peritoneal mesothelioma patients and others who underwent cytoreductive surgery and intraperitoneal chemotherapy. Their findings suggests that experience improves survival. Click here to read the full story on the Surviving Mesothelioma website.
Doctors at the University of New South Wales in Australia analyzed the outcomes of 800 mesothelioma patients and others who had the CRS/PIC combination treatment between 1996 and 2014.
“Our findings demonstrate a learning curve associated with the combined approach of CRS and PIC,” writes lead author Yeqian Huang, MD. “With adequate experience, CRS and PIC can be safely performed with acceptable mortality and morbidity.”
The study, published in the ANZ Journal of Surgery, found that the most recent peritoneal mesothelioma surgery patients had a much better five-year survival rate than those treated earlier. They also had fewer complications.
“The message for peritoneal mesothelioma patients here is that it pays to search for a center with more mesothelioma surgical experience,” says Surviving Mesothelioma’s Managing Editor, Alex Strauss.
For the details of the Australian study, as well as resources to help patients and families find and choose a treatment facility, see More Experience Equals Better Outcomes for Peritoneal Mesothelioma, now available on the Surviving Mesothelioma website.
Huang, Y, et al, “Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis”, September 2, 2015, ANZ Journal of Surgery, Epub ahead of print, http://onlinelibrary.wiley.com/doi/10.1111/ans.13280/abstract
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.